Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Cessation Therapies for Smoking Cessation
NCT01406223Phase 3Completed
- Sponsor
- Duke University
- Start
- Jul 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline, bupropion, nicotine in nicotine dependence, sponsored by Duke University. Started Jul 2011; status: completed.
02
Drugs
vareniclinebupropionnicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01406223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01406223.